Ansell Ltd
Company Profile
Business description
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Contact
678 Victoria Street
Level 3
Richmond
MelbourneVIC3121
AUST: +61 392707222
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2026
Employees
15,724
Ansell Ltd News & Analysis
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
stocks
ASX healthcare stocks shrug off new tariff threat
stocks
3 cheap ASX shares with sound balance sheets
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,059.10 | 29.60 | 0.33% |
CAC 40 | 7,827.45 | 44.57 | -0.57% |
DAX 40 | 23,666.81 | 55.48 | 0.23% |
Dow JONES (US) | 46,121.28 | 171.50 | -0.37% |
FTSE 100 | 9,250.43 | 27.11 | 0.29% |
HKSE | 26,479.19 | 39.46 | -0.15% |
NASDAQ | 22,497.86 | 75.62 | -0.33% |
Nikkei 225 | 45,724.21 | 93.90 | 0.21% |
NZX 50 Index | 13,153.79 | 27.52 | -0.21% |
S&P 500 | 6,637.97 | 18.95 | -0.28% |
S&P/ASX 200 | 8,769.00 | 31.10 | 0.36% |
SSE Composite Index | 3,845.40 | 8.24 | -0.21% |